focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Europe down after Easter holiday weekend

Tue, 02nd Apr 2024 16:57

(Alliance News) - The FTSE 100 took a hit on Tuesday, after a boost from London's miners and oil firms were not enough to lift the index.

The FTSE 100 index closed down 17.53 points, 0.2%, at 7,935.09. The FTSE 250 ended down 170.84 points, 0.9%, at 19,713.89, and the AIM All-Share closed down 0.86 of a point, 0.1%, at 742.40.

The Cboe UK 100 ended down 0.3% at 793.40, the Cboe UK 250 closed down 1.1% at 17,147.56, and the Cboe Small Companies ended down slightly at 14,553.13.

In European equities on Tuesday, the CAC 40 in Paris ended down 0.9%, while the DAX 40 in Frankfurt ended down 1.1%.

After a long Easter weekend, markets reopened on Tuesday to a busy day on the corporate and economic calendar.

Data from S&P Global on Tuesday showed the UK manufacturing sector crossing the no-change mark into growth territory in March.

The seasonally adjusted S&P Global UK manufacturing purchasing managers' index reading was 50.3 points in March, up from 47.5 in February and beating the earlier flash estimate of 49.9.

The latest figure was above the 50-point no-change mark, meaning the UK manufacturing sector returned to growth territory.

PMI data from the eurozone was more disheartening, however.

The latest Hamburg Commercial Bank manufacturing PMI fell to 46.1 points in March, from 46.5 in February. The latest reading was a three-month low, but topped the flash estimate of 45.7 points.

Hamburg Commercial Bank analyst Cyrus de la Rubia commented: "It's a bit disheartening: over the last eight months, the manufacturing industry has been gradually climbing the output PMI ladder, but it still finds itself on the basement staircase."

More positively for the eurozone, Germany saw inflation ease in March.

The consumer price index rose by 2.2% annually in March, ebbing from a 2.5% rise in February. This came in line with FXStreet-cited market consensus and is the lowest value since April 2021.

Analysts at ING said: "despite the early timing of Easter this year, prices for leisure, packaged holidays and hotels and restaurants rose less than expected month-on-month than expected. The Easter bunny effect, ie the base effect stemming from the timing of Easter, was hardly visible this year."

The pound was quoted at USD1.2564 at the London equities close Tuesday, lower compared to USD1.2640 at the close on Thursday. The euro stood at USD1.0771 at the European equities close Tuesday, down against USD1.0803 at the same time on Thursday. Against the yen, the dollar was trading at JPY151.60, up compared to JPY151.29 late Thursday.

In the FTSE 100, miners were among the better large-cap performers. Fresnillo, Anglo American, Glencore, and Rio Tinto traded 7.6%, 4.6%, 3.0%, and 2.0% higher respectively.

The miners got a boost from the latest set of PMI data from China. Monthly factory activity in China grew for the first time in half a year, official figures showed, in a positive sign for policymakers seeking to revive the world's second-largest economy.

The PMI came in at 50.8 points in March, according to the National Bureau of Statistics, up from 49.1 in February. The last expansion in China's monthly PMI was in September, with factory activity consistently negative since then, according to NBS data.

The trend of improvement was confirmed by the Caixin manufacturing PMI, which edged up to 51.1 from 50.9.

Oil firms also did well on Tuesday, on the back of higher oil prices. Shell and BP rose 3.2% and 2.5% respectively.

Brent oil was quoted at USD88.11 a barrel at the London equities close Tuesday, up from USD86.56 late Thursday.

"The ongoing rise in oil prices amid a tighter supply outlook is a worry for corporates and consumers as it is a major inflationary force," said Russ Mould, investment director at AJ Bell.

On the other hand, housebuilders were in the red. Taylor Wimpey, Persimmon, and Barratt Developments lost 3.1%, 3.5%, and 0.1%, respectively.

They were hit by a fall in house prices in the most recent month.

The Nationwide house price index showed a 0.2% decline in seasonally adjusted UK house prices in March from February, compared to a 0.7% rise in February from January. According to FXStreet, market consensus expected the house price index to rise 0.3% last month.

Annually, the house price index rose 1.6% in March compared to a year ago, improving from an annual rise of 1.2% in February, but undershooting FXStreet-cited expectations of a 2.4% rise.

Elsewhere in London, on AIM, Orcadian Energy surged 86%.

The oil and gas development company said it has completed the farm-out of 81% interest in Licence P2244, which contains the Pilot field, to Ping Petroleum UK PLC. Ping is focused on shallow water offshore production, and has a significant acreage holding to the East of Pilot.

On the other hand, Redx Pharma plummeted 65%, after it said it intends to cancel its shares from trading on AIM in London.

The clinical-stage biotechnology company said the board unanimously concluded that it is in the best interests of the company to re-register as a private limited company, as it is "still liquidity constrained" on AIM.

Chair Jane Griffith said: "The board believes that as a private company we can access a broader universe of specialty investors and, accordingly, a larger quantum of future funding required to execute our strategy and maximise our value in the interests of all our shareholders."

Stocks in New York were lower at the London equities close, with the DJIA down 1.1%, the S&P 500 index down 0.9%, and the Nasdaq Composite down 1.2%.

Gold was quoted at USD2,266.55 an ounce at the London equities close Tuesday, up against USD2,221.01 at the close on Thursday.

In Wednesday's UK corporate calendar, there are full year results from Hilton Food, Impax Environmental Markets, and Pantheon Infrastructure.

The economic calendar for Wednesday has unemployment and CPI data from the eurozone out at 1000 BST.

There are also a number of Federal Reserve members who are scheduled to speak, including Fed Chair Jerome Powell, Vice Chair Michale Barr, Governor Michelle Bowman, and Governor Adriana Kugler.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
10 Jul 2019 10:40

WINNERS & LOSERS SUMMARY: PageGroup Slumps After Profit Warning

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - LOSERS----------Micro Focus down

Read more
10 Jul 2019 09:41

Redx Pharma Shares Double After Jazz Pharmaceutical Deal

(Alliance News) - Redx Pharma PLC said Wednesday it has signed a definitive agreement with Nasdaq-listed Jazz Pharmaceuticals PLC to sell its pan-RAF inhibitor programme.Shares in the and a

Read more
10 Jun 2019 10:10

Redx Pharma Gets GBP2.5 Million Financing As Interim Loss Narrows

LONDON (Alliance News) - Redx Pharma PLC on Monday said its loss narrowed in the first half of its current financial year as it progresses on cancer and idiopathic pulmonary fibrosis drugs the and

Read more
10 Jun 2019 08:29

Redx Pharma narrows losses as RXC004 trials recommence

(Sharecast News) - Drug discovery and development company Redx Pharma published its interim results on Monday, revealing it had narrowed first-half losses as it progresses on cancer and idiopathic pulmonary fibrosis drugs development.

Read more
3 May 2019 14:07

Redx Pharma Exploring New Financing Options Despite Progress

LONDON (Alliance News) - Cancer and fibrosis-focused drug firm Redx Pharma PLC is "greatly encouraged" by talks over securing new financing.In November, Redx said it was looking a

Read more
3 May 2019 11:17

Redx Pharma extends cash runway into July

(Sharecast News) - Drug discovery and development company Redx Pharma updated the market on its ongoing plans to strengthen its balance sheet on Friday, with its board reiterating its commitment to strengthening the balance sheet in order to extend the cash runway beyond the second quarter of 2019, as it initially announced in November.

Read more
12 Feb 2019 13:42

Redx Pharma reveals promising data on 'ROCK2' compound

(Sharecast News) - Drug discovery and development company Redx Pharma announced promising preclinical efficacy data for its lead selective 'ROCK2' compound on Tuesday.

Read more
12 Feb 2019 09:45

Redx Pharma Sees Promising Results From Liver Disease Treatment

LONDON (Alliance News) - Redx Pharma PLC said Tuesday that preclinical efficacy data for its ROCK2 compound showed the product was able to have an impact on established fibrosis.Shares in a

Read more
6 Feb 2019 11:45

Redx Pharma Receives Oustanding Loan Amounts From Redag

LONDON (Alliance News) - Redx Pharma PLC on Wednesday said that it received a full cash repayment of GBP869,126, representing the outstanding amount of a loan made in 2014 to Redag Crop Protection

Read more
31 Jan 2019 11:03

Deinove Backs Out Of Anti-Infective NBTI Programme With Redx Pharma

LONDON (Alliance News) - Redx Pharma PLC on Thursday said French biotech firm Deinove SA will not exercise its option for Redx's novel bacterial topoisomerase inhibitor programme.Shares

Read more
31 Jan 2019 09:45

Deinove hands rights to NBTI programme back to Redx Pharma

(Sharecast News) - Drug discovery and development company Redx Pharma announced on Thursday that Deinove had decided not to exercise its option for Redx's 'Novel Bacterial Topoisomerase Inhibitor' (NBTI) programme.

Read more
30 Nov 2018 10:36

Redx Pharma Drug Candidate RXC006 To Be Developed As Fibrosis Drug

LONDON (Alliance News) - Drug developer Redx Pharma PLC said Friday its RXC006 drug candidate was able to suppress lung fibrosis in living organisms and will be developed as a treatment for in up

Read more
30 Nov 2018 10:31

Redx Pharma jumps as first data shows 'great potential' for fibrosis candidate

(Sharecast News) - Redx Pharma made gains on Friday after it said that pre-clinical data suggested that its RXC006 drug candidate has "great potential" as a treatment for fibrosis.

Read more
19 Nov 2018 13:07

Redx Pharma Posts Large Annual Loss, Appoints Astra Executive As CFO

LONDON (Alliance News) - Redx Pharma PLC on Monday posted a large loss due to the absence of a big exceptional disposal gain seen a year before and said that it has appointed James Mead as its new

Read more
19 Nov 2018 08:59

Redx Pharma swings to a loss following 'seminal' year

(Sharecast News) - A year after clambering out of administration, drug discovery and development outfit Redx Pharma swung to a loss but remains confident of making progress with a drug pipeline refocused on cancer and fibrosis.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.